Robot maker · early
MegaRobo Technologies
Proprietary lightweight collaborative robot arms with vision and force-sensing control integrated into laboratory automation platforms (MegaFluent); arms connect instruments for fully automated workflows in genomic sequencing, clinical diagnostics, drug discovery, and synthetic biology. Presented at MEDICA 2023.
Company overview
Identity and operating footprint
Robot models
Specifications remain vendor-claimed
CDS-610
- Highest-throughput sample reformatter; closed negative pressure system integrating steps requiring extensive manual operation for fully automated sample preparation in clinical diagnostics
Vendor-stated description of the CDS-610 clinical diagnostics sample reformatter
Claim source
MegaFluent
- General-purpose laboratory automation platform using MEGAROBO collaborative robot arms to interconnect laboratory instruments for fully automatic pipetting, sample handling, and experiment workflows; supports unmanned lab operation
Vendor-stated product description of the MegaFluent laboratory automation platform
Claim source
Funding history
Publicly announced rounds
Series C
GGV Capital, Goldman Sachs Growth Equity, Asia Investment Capital, Sinovation Ventures, Pavilion Capital, Starr Capital
Round sourceSeries B
Round sourceSeries B
WuXi AppTec, Joy Capital, Sinovation Ventures, Matrix Partners China, Robert Bosch Venture Capital, Future Capital, Liando Investment
Round sourceSeries A
Round sourceSeed
Investors undisclosed
Round sourceUndisclosed
Investors undisclosed
Round sourceCompany timeline
Milestones and announcements
Source ledger
6 unique public sources